High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: An Australian perspective

Psycho-Oncology

Volumn 17, Issue 3, 2008, Pages 270-279

  Kasparian, Nadine A ^a,b,c   Butow, Phyllis N ^a   Meiser, Bettina ^b,c   Mann, Graham J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cancer; Causal attributions; Familial melanoma; Oncology; Perceived risk

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO ILLNESS; AUSTRALIA; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; COPING BEHAVIOR; DATA ANALYSIS; DECISION MAKING; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HEALTH BEHAVIOR; HEALTH BELIEF; HEREDITY; HIGH RISK PATIENT; HUMAN; MALE; MELANOMA; PSYCHOSOCIAL ENVIRONMENT; RISK ASSESSMENT; RISK REDUCTION; SCREENING; SEMI STRUCTURED INTERVIEW; SUN EXPOSURE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AFFECT; ATTITUDE TO HEALTH; AUSTRALIA; CULTURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH BEHAVIOR; HELIOTHERAPY; HUMANS; INTERVIEWS AS TOPIC; MALE; MELANOMA; MIDDLE AGED; PSYCHOLOGY; RISK FACTORS; SKIN NEOPLASMS;

EID: 40949094062     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1230     Document Type: Article

References (53)

1. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2001. AIHW Cat. No. CAN 23, Cancer Series No. 28, AIHW, Canberra, 2004.
2. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993;3(6): 395-401.
3. Armstrong BK. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 1988; 14(8):835-849.
4. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005;41(14):2040-2059.
5. Bliss JM, Ford D, Swerdlow AJ et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case - control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;62(4):367-376.
6. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63(1-3):8-18.
7. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17(3):459-468.
8. Tucker MA, Halpern A, Holly EA et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. J Am Med Assoc 1997;277(18): 1439-1444.
9. Florell S, Boucher K, Garibotti G et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005;23(28):7168-7177.
10. Goldstein A, Struewing J, Fraser M, Smith M, Tucker M. Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet 2004;41(6):421-425.
11. Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG. Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 1994;140(11): 961-973.
12. Easton DF, Cox GM, Macdonald AM, Ponder BA. Genetic susceptibility to naevi - a twin study. Br J Cancer 1991;64(6):1164-1167.
13. Goldstein A, Chan M, Harland M et al. Assessment of high-risk melanoma susceptibility genes and their associations with pancreatic cancer, neural system tumors, and uveal melanoma: a Melanoma Genetics Consortium (GenoMEL) study. Cancer Res 2006;66: 9818-9828.
14. McGuire D. Impact of hereditary melanoma on families. Cancer Nurs 1984;7(6):451-459.
15. McGuire D. Preventive health practices and educational needs in families with hereditary melanoma. Cancer Nurs 1985;8(1):29-36.
16. Bergenmar M, Brandberg Y. Sunbathing and sun-protection behaviors and attitudes of young Swedish adults with hereditary risk for malignant melanoma. Cancer Nurs 2001;24(5):341-350.
17. Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S. Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev Med 2004;39:36-47.
18. Geller A, Emmons K, Brooks D et al. Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol 2003;49: 631-638.
19. Riedijk S, de Snoo F, van Dijk S et al. Hereditary melanoma and predictive genetic testing: Why not? Psycho-Oncology 2005; 14:738-745.
20. Brandberg Y, Bolund C, Sigurdardottir V, Sjoden P-O, Sullivan M. Anxiety and depressive symptoms at different stages of malignant melanoma. Psycho-Oncology 1992;1(2):71-78.
21. Brandberg Y, Bergenmar M, Bolund C, Mansson-Brahme E, Ringborg U, Sjoden PO. Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma. Eur J Cancer 1992;28A(8-9): 1334-1338.
22. Masri GD, Clark Jr WH, Guerry Dt, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990; 22(6 Pt 1):1042-1048.
23. Jackson A, Wilkinson C, Hood K, Pill R. Does experience predict knowledge and behaviour with respect to cutaneous melanoma, moles, and sun exposure? Possible outcome measures. Behav Med 2000; 26(2):74-79.
24. Azzarello LM, Jacobsen PB. Factors influencing participation in cutaneous screening among individuals with a family history of melanoma. J Am Acad Dermatol 2007;56(3):398-406.
25. Azzarello L, Dessureault S, Jacobsen P. Sun-protective behaviour among individuals with a family history of melanoma. Cancer Epidemiol Biomarkers Prev 2006; 15(1): 142-145.
26. Kasparian N, Meiser B, Butow P, Job R, Mann GJ. Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility. J Genet Couns 2006; 15: 433-447.
27. Kasparian N, Meiser B, Butow P, Job R, Mann G. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: an exploratory study. Psycho-Oncology 2007;16:69-78.
28. Bishop D, Demenais F, Goldstein A et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002;94:894-903.
29. Patton M. Qualitative Evaluation and Research Method (2nd edn). Sage Publications: London, 1990.
30. Denzin N, Lincoln Y (eds). Handbook of Qualitative Research. Sage Publications: Thousand Oaks, CA, US, 1994.
31. Miles M, Huberman A. Qualitative Data Analysis: An Expanded Sourcebook. Sage: London, 1994.
32. Huberman A, Miles M. Data management and analysis methods. In Handbook of Qualitative Research, Denzin N, Lincoln Y (eds). Sage Publications: Thousand Oaks, CA, US, 1994; 428-444.
33. Conner M, Norman P (eds). Predicting Health Behaviour: Research and Practice With Social Cognition Models. Open University Press: Buckingham, England, 2005.
34. Andrews L, Meiser B, Apicella C, Tucker K. Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet Test 2004; 8(3): 240-247.
35. Schwartz M, Hughes C, Roth J et al. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev 2000;9(4): 381-385.
36. Lerman C, Schwartz M, Narod S, Hsiang Lin T, Hughes C, Lynch H. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65(3):414-420.
37. Foster C, Evans D, Eeles R et al. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test 2004;8(1):23-29.
38. Codori A-M, Petersen G, Miglioretti D et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev 1999;8: 345-351.
39. Chaliki H, Loader S, Levenkron J, Logan-Young W, Hall W, Rowley P. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 1995;85:1133-1135.
40. Andrykowski M, Munn R, Studts J. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med 1996;25:527-536.
41. Tambor E, Rimer B, Strigo T. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am J Med Genet 1997;68:43-49.
42. Weinstein N, Nicolich M. Correct and incorrect interpretations of correlations between risk perceptions and risk behaviours. Health Psychol 1993;12(3): 235-245.
43. Aiken L, Fenaughty A, West S, Johnson J, Luckett T. Perceived determinants of risk for breast cancer and the relations among objective risk, perceived risk, and screening behavior over time. Women Health Res Gender Behav Pol 1995;1(1):27-50.
44. Bandura A. Self-efficacy mechanism in physiological activation and health promoting behavior. In Adaptation, Learning and Affect, Madden IV J, Matthysse S, Barchas J (eds). Raven Press: New York, 1986.
45. Seydel E, Taal E, Wiegman O. Risk-appraisal, outcome and self-efficacy expectancies: cognitive factors in preventive behaviour related to cancer. Psychol Health 1990;4:99-109.
46. Marteau T, Lerman C. Genetic risk and behavioural change. Br Med J 2001;322(7293):1056-1059.
47. Marteau T, Senior V. Illness representations after the human genome project: the perceived role of genes in causing illness. In Perceptions of Illness and Treatment: Current Psychological Research and Implications, Petri KJ, Weinman J (eds). Ilarwood Academic Press: Amsterdam, 1997; 241-264.
48. Michie S, McDonald V, Marteau T. Understanding responses to predictive genetic testing: a grounded theory approach. Psychol Health 1996;11(4):455-470.
49. Lippman-Hand A, Fraser F. Genetic counselling: patients' responses to uncertainty. In Risk, Communication, and Decision Making in Genetic Counseling, Epstein C, Curry C, Packman S, Sherman S (eds). Alan R Liss: New York, 1979.
50. Kelley H. Causal schemata and the attribution process. In Attribution: Perceiving the Causes of Behaviour, Jones E, Kanouse D, Kelley H, Nisbett R, Valins S, Weiner B (eds). General Learing Press: Morristown, NJ, 1971.
51. McAllister M. Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003; 64:179-189.
52. Senior V, Marteau T, Weinman J. Impact of genetic testing on causal models of heart disease and arthritis: an analogue study. Psychol Health 2000;14:1077-1088.
53. Severi G, Giles G, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000;82(11):1887-1891.